Fulgent Genetics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $81,803 | $73,463 | $76,214 | $71,743 |
Gross Profit | 34,435 | 28,346 | 31,849 | 26,771 |
EBITDA | -15,448 | -5,790 | -9,943 | -12,598 |
EBIT | -21,502 | -11,709 | -16,135 | -18,518 |
Net Income | -18,957 | -11,530 | -5,888 | -14,648 |
Net Change In Cash | 81,803 | 73,463 | 76,214 | 71,743 |
Free Cash Flow | -36,997 | -9,149 | 21,240 | -35,046 |
Cash | 87,880 | 67,281 | 55,144 | 58,042 |
Basic Shares | 30,832 | 30,832 | 30,652 | 30,416 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $283,470 | $289,213 | $618,968 | $992,584 |
Gross Profit | 107,215 | 104,456 | 366,901 | 777,051 |
EBITDA | -48,990 | -46,552 | 221,585 | 106,047 |
EBIT | -73,918 | -72,695 | 184,675 | 104,339 |
Net Income | -42,708 | -167,825 | 143,403 | 104,339 |
Net Change In Cash | 283,470 | 289,213 | 618,968 | 992,584 |
Cost of Revenue | 77,434 | |||
Free Cash Flow | -19,255 | 4,796 | 234,745 | 514,733 |
Cash | 55,144 | 97,473 | 79,506 | 164,894 |
Basic Shares | 30,235 | 29,784 | 30,964 | 30,976 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.07 |
2025-03-31 | $0.04 |
2024-12-31 | $0.04 |
